Wound botulism
diseaseOn this page
Also known as cutaneous infectious botulismcutaneous toxin-mediated botulisminoculation botulismskin infectious botulismskin toxin-mediated botulism
Summary
Wound botulism (MONDO:0015803) is a disease. A subtype of toxin-mediated infectious botulism — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 15
Clinical features
Epidemiology
Prevalence records
1 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.1 | Europe | Validated |
Signs & symptoms
Clinical features (HPO)
15 HPO clinical features (Orphanet curated; top 15 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000508 | Ptosis | Very frequent (80-99%) |
| HP:0000651 | Diplopia | Very frequent (80-99%) |
| HP:0001260 | Dysarthria | Very frequent (80-99%) |
| HP:0001324 | Muscle weakness | Very frequent (80-99%) |
| HP:0002015 | Dysphagia | Very frequent (80-99%) |
| HP:0002019 | Constipation | Very frequent (80-99%) |
| HP:0006597 | Diaphragmatic paralysis | Very frequent (80-99%) |
| HP:0006824 | Cranial nerve paralysis | Very frequent (80-99%) |
| HP:0011499 | Mydriasis | Very frequent (80-99%) |
| HP:0100021 | Cerebral palsy | Very frequent (80-99%) |
| HP:0000016 | Urinary retention | Frequent (30-79%) |
| HP:0002094 | Dyspnea | Frequent (30-79%) |
| HP:0002747 | Respiratory insufficiency due to muscle weakness | Frequent (30-79%) |
| HP:0001695 | Cardiac arrest | Occasional (5-29%) |
| HP:0001945 | Fever | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | wound botulism |
| Mondo ID | MONDO:0015803 |
| Orphanet | 178475 |
| DOID | DOID:0050353 |
| ICD-10-CM | A48.52 |
| ICD-11 | 1674998448 |
| NCIT | C128342 |
| SNOMED CT | 398530003 |
| UMLS | C1306794 |
| MedGen | 224933 |
| GARD | 0020149 |
| Is cancer (heuristic) | no |
Also known as: cutaneous infectious botulism · cutaneous toxin-mediated botulism · inoculation botulism · skin infectious botulism · skin toxin-mediated botulism
Disease family
This is a subtype of toxin-mediated infectious botulism. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › primary bacterial infectious disease › botulism › toxin-mediated infectious botulism › wound botulism
Related subtypes (1): intestinal botulism
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.